Evalutation of the multidimensional assessement-tool RoBa (Ressource oriented analysis of demand) to gather the activity, nutrition and quality of life status of cancer patients
- Conditions
- colorectal cancer, pancreatic cancerMalnutrition, physical inactivity, chronic inflammation
- Registration Number
- DRKS00026620
- Lead Sponsor
- MU Klinikum, Medizinische Klinik und Poliklinik III
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
primary cancer diganosis (colorectal cancer, pancreatic cancer) before or at the beginning of cancer treatment
life expactancy = 12 months
ECOG = 2
Written and valid informed consent
contraindication against the spiroergometry:
- severe coronary insufficiency (NYHA III-IV)
- therapy refractory high blood pressure III-IV°
- respiratory insufficiency, COPD >III°
- therapy refractory thrombocytopenia < 10.000/µl
- uncontrolled hemorrhagic diathesis
- instable coronary syndrom
- instable cardiac arrhythmias
- unconsontrolled cerebric epilepsy
contraindication against bioimpedance analysis:
- implanted pacemaker or defibrillator
- Non-detachable, active protheses with electric control
pregnancy
Missing informed consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical feasibility of the RoBa-assessment as a whole with it´s twelve single tests
- Secondary Outcome Measures
Name Time Method - comparison of the validity and results of the single assessments with the results in the aggregated score.<br>- Analysis of subgroups regarding tumor entity, tumor stage, ECOG, gender